Glucuronomannan GM2 from Saccharina japonica Enhanced Mitochondrial Function and Autophagy in a Parkinson’s Model
Open Access
- 25 January 2021
- journal article
- research article
- Published by MDPI AG in Marine Drugs
- Vol. 19 (2), 58
- https://doi.org/10.3390/md19020058
Abstract
Parkinson’s disease (PD), one of the most common neurodegenerative disorders, is caused by dopamine depletion in the striatum and dopaminergic neuron degeneration in the substantia nigra. In our previous study, we hydrolyzed the fucoidan from Saccharina japonica, obtaining three glucuronomannan oligosaccharides (GMn; GM1, GM2, and GM3) and found that GMn ameliorated behavioral deficits in Parkinsonism mice and downregulated the apoptotic signaling pathway, especially with GM2 showing a more effective role in neuroprotection. However, the neuroprotective mechanism is unclear. Therefore, in this study, we aimed to assess the neuroprotective effects of GM2 in vivo and in vitro. We applied GM2 in 1-methyl-4-phenylpyridinium (MPP+)-treated PC12 cells, and the results showed that GM2 markedly improved the cell viability and mitochondrial membrane potential, inhibited MPP+-induced apoptosis, and enhanced autophagy. Furthermore, GM2 contributed to reducing the loss of dopaminergic neurons in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mice through enhancing autophagy. These data indicate that a possible protection of mitochondria and upregulation of autophagy might underlie the observed neuroprotective effects, suggesting that GM2 has potential as a promising multifunctional lead disease-modifying therapy for PD. These findings might pave the way for additional treatment strategies utilizing carbohydrate drugs in PD.Keywords
Funding Information
- China Postdoctoral Science Foundation (NO. 2018M640611)
This publication has 44 references indexed in Scilit:
- Allicin Protects PC12 Cells Against 6-OHDA-Induced Oxidative Stress and Mitochondrial Dysfunction via Regulating Mitochondrial DynamicsCellular Physiology and Biochemistry, 2015
- Autophagy and apoptosis dysfunction in neurodegenerative disordersProgress in Neurobiology, 2014
- Neuro-protective effects of bee venom by suppression of neuroinflammatory responses in a mouse model of Parkinson’s disease: Role of regulatory T cellsBrain, Behavior, and Immunity, 2012
- Rapamycin As an Antiaging Therapeutic?: Targeting Mammalian Target of Rapamycin to Treat Hutchinson–Gilford Progeria and Neurodegenerative DiseasesRejuvenation Research, 2011
- Dopaminergic Projections from Midbrain to Primary Motor Cortex Mediate Motor Skill LearningJournal of Neuroscience, 2011
- Pathogenic Lysosomal Depletion in Parkinson's DiseaseJournal of Neuroscience, 2010
- Autophagy: cellular and molecular mechanismsThe Journal of Pathology, 2010
- [123I]beta-CIT SPECT is a useful method for monitoring dopaminergic degeneration in early stage Parkinson's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2003
- Experimental models of Parkinson's diseaseNature Reviews Neuroscience, 2001
- Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosisNature, 1995